Management of Hypercortisolism with Negative CT for Adrenal Mass
When cortisol is elevated but CT shows no adrenal mass, immediately measure ACTH levels to distinguish ACTH-dependent from ACTH-independent causes, as this determines whether the source is pituitary, ectopic, or represents bilateral adrenal hyperplasia that may not appear as a discrete mass on imaging. 1, 2
Initial Diagnostic Algorithm
Step 1: Confirm True Hypercortisolism
- Verify elevated 24-hour urinary free cortisol and ensure the 1 mg dexamethasone suppression test was valid (cortisol >138 nmol/L or >5.0 mg/dL indicates autonomous secretion) 1
- If prior testing was invalid or borderline, repeat with simultaneous measurement of serum dexamethasone levels at 8 AM to confirm adequate drug absorption 3
- Assess late-night salivary cortisol to confirm loss of circadian rhythm 4
Step 2: Measure Plasma ACTH
This is the critical branch point that determines your entire diagnostic pathway. 1, 2
If ACTH is Elevated or Normal (ACTH-Dependent):
- Pituitary source (Cushing's disease): Order pituitary MRI to identify adenoma 1, 2
- Ectopic ACTH syndrome: Perform high-dose dexamethasone suppression test (8 mg) - failure to suppress suggests ectopic source 1
- Consider CT chest/abdomen/pelvis to identify neuroendocrine tumors in lung, thyroid, pancreas, or bowel as ectopic ACTH sources 1
- Perform bilateral inferior petrosal sinus sampling with CRH stimulation if pituitary MRI is negative but ACTH-dependent hypercortisolism is confirmed - petrosal-to-peripheral ACTH ratio >2 at baseline or >3 after CRH indicates pituitary source 2
If ACTH is Suppressed/Undetectable (ACTH-Independent):
This indicates primary adrenal pathology even without a visible mass on CT. 1, 2
- Bilateral micronodular or macronodular adrenal hyperplasia: These conditions may not produce a discrete mass >1 cm that appears on standard CT 5, 2
- Order dedicated adrenal protocol MRI with chemical shift imaging, which is superior to CT for detecting subtle bilateral hyperplasia 2
- Consider ACTH stimulation test: exaggerated cortisol response (>550 nmol/L or >20 mcg/dL) with suppressed ACTH suggests ACTH-independent macronodular hyperplasia with aberrant receptor expression 5
- Measure 17-hydroxyprogesterone and 11-deoxycortisol during ACTH stimulation to exclude late-onset congenital adrenal hyperplasia, though exaggerated cortisol response makes this unlikely 5
Common Pitfalls to Avoid
Imaging Limitations
- Standard abdominal CT may miss bilateral micronodular disease (nodules <1 cm) or early macronodular hyperplasia 2
- Always obtain non-contrast CT first to measure Hounsfield units, then proceed to MRI if CT is negative but biochemistry confirms hypercortisolism 1, 6
Physiologic vs. Pathologic Hypercortisolism
- Exclude physiologic/non-neoplastic causes before pursuing invasive testing: severe alcoholism, uncontrolled diabetes, renal failure, severe depression, or other neuropsychiatric disorders can cause hypercortisolism without neoplasia 4
- If these conditions are present, treat the underlying disorder and retest after 3-6 months 4
False Negatives on Screening
- Cyclic Cushing's syndrome causes intermittent hypercortisolism - if clinical suspicion remains high despite one negative workup, repeat testing during symptomatic periods 4
Management Based on Final Diagnosis
For Pituitary Cushing's Disease:
- Transsphenoidal surgery is first-line treatment 7
- Medical management with pasireotide, cabergoline, or ketoconazole if surgery fails or is contraindicated 7
For Ectopic ACTH Syndrome:
- Surgical resection of ectopic tumor if localized and resectable 1
- If primary tumor is unresectable or occult, consider bilateral laparoscopic adrenalectomy or medical management with steroidogenesis inhibitors (ketoconazole, metyrapone, osilodrostat) 1, 7
For Bilateral Adrenal Hyperplasia (ACTH-Independent):
- Bilateral adrenalectomy is definitive treatment for ACTH-independent macronodular hyperplasia causing clinically significant Cushing's syndrome 1, 2
- Lifelong glucocorticoid and mineralocorticoid replacement is required post-operatively 1
- Medical management is an alternative if surgery is refused or contraindicated, using steroidogenesis inhibitors 7
For Subclinical Hypercortisolism Without Discrete Mass:
- Younger patients with progressive metabolic comorbidities (hypertension, diabetes, obesity, osteoporosis) attributable to cortisol excess should be offered bilateral adrenalectomy after shared decision-making 1, 3
- Patients not managed surgically require annual clinical screening for worsening metabolic complications 1
Multidisciplinary Review Threshold
- Obtain immediate consultation with endocrinology, surgery, and radiology when biochemical hypercortisolism is confirmed but imaging is negative or indeterminate 1, 6
- This team approach is essential for determining whether to pursue petrosal sinus sampling, repeat advanced imaging, or proceed directly to bilateral adrenalectomy 1